The global whey protein market size is predicted to increase from USD 9.78 billion in 2024, grow to USD 10.65 billion in 2025, and is anticipated to reach around USD 22.95 billion by 2034, poised to grow at a CAGR of 8.9% between 2024 and 2034. The North America whey protein market size is calculated at USD 3.72 billion in 2024 and is estimated to grow at the fastest CAGR of 9.05% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Whey Protein Market
5.1. COVID-19 Landscape: Whey Protein Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Whey Protein Market, By Type
8.1. Whey Protein Market, by Type, 2024-2034
8.1.1. Isolates
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Concentrates
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Demineralized
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Hydrolysate
8.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Whey Protein Market, By Application
9.1. Whey Protein Market, by Application, 2024-2034
9.1.1. Nutritional
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Personal Care
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Food
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Feed
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Infant Formula
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Sports and Performance Nutrition
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Functional/Fortified Food
9.1.7.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Whey Protein Market, By Distribution channel
10.1. Whey Protein Market, by Distribution channel, 2024-2034
10.1.1. Supermarkets/Hypermarkets
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Convenience Stores
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Specialty Stores
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Online Stores
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Other Distribution Channels
10.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Whey Protein Market, By End Users
11.1. Whey Protein Market, by End Users, 2024-2034
11.1.1. Athletes
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Bodybuilders
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Lifestyle Users
11.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Whey Protein Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.1.4. Market Revenue and Forecast, by End Users (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.2.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.3.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.4.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End Users (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Distribution channel (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End Users (2021-2034)
Chapter 13. Company Profiles
13.1. Glanbia plc. (Ireland)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Now Health Group, Inc. (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nutiva Inc (U.S.)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. The Simply Good Food Co (U.S.)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Iovate Health Sciences International Inc. (Canada)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. MusclePharm Corporation (U.S.)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Kerry Group Plc (Ireland)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. CytoSport, Inc. (U.S.)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. The Nature's Bounty Co. (U.S.)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Reliance Vitamin Company, Inc. (U.S.)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample